Welcome to our dedicated page for Adient SEC filings (Ticker: ADNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Adient plc (NYSE: ADNT) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Adient, an Irish‑incorporated automotive seating company, uses SEC reports to communicate material events, financial results and key agreements that shape its capital structure and operations.
Investors can review current reports on Form 8‑K in which Adient furnishes quarterly and full‑year earnings releases under the results of operations and financial condition item. These filings typically attach press releases as exhibits and describe how the information is treated for Exchange Act purposes. Other 8‑K filings detail material definitive agreements, such as amendments to the company’s revolving credit agreement that extend maturity dates or adjust aggregate commitments, and note that obligations are guaranteed on a secured basis by Adient and certain material wholly owned restricted subsidiaries.
Adient also uses 8‑K filings for Regulation FD disclosures, including investor presentation materials used in meetings with shareholders and prospective investors. Together with annual reports on Form 10‑K and other periodic reports, these documents outline risk factors, non‑GAAP financial measures, business performance indicators and other information relevant to understanding Adient’s financial condition and strategy.
On Stock Titan, these filings are updated as they appear on EDGAR and are paired with AI‑powered summaries that explain the key points in clear language. Users can quickly see what each filing covers, from earnings announcements and credit facility changes to investor presentations, without reading every page. For deeper analysis, investors can open the full text of each filing, while relying on the AI insights to highlight items that may affect Adient’s balance sheet, liquidity, seating operations and overall risk profile.
Adient plc (ADNT)November 13, 2025, the officer received 42,553 restricted stock units that vest in three equal installments on the first, second and third anniversaries of the grant date, and 7,036 performance share units earned for the three-year period ended September 30, 2025. On November 14 and November 16, 2025, a total of 6,810 ordinary shares were withheld at $20.02 per share to cover taxes due on vesting. After these transactions, the officer beneficially owned 135,367.22 ordinary shares directly and 3,898.49 shares indirectly through the company 401(k) Savings Plan.
FMR LLCAdient plc (ADNT). As of the event date 09/30/2025, FMR LLC reported beneficial ownership of 4,985,555.65 shares of common stock, representing 6.1% of the class.
FMR LLC reported sole voting power over 4,955,055.00 shares and sole dispositive power over 4,985,555.65 shares, with no shared voting or dispositive power. Abigail P. Johnson is also a reporting person, with sole dispositive power over 4,985,555.65 shares and no voting power.
The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
Adient plc furnished a Form 8-K announcing its fourth-quarter and fiscal year results for the period ended September 30, 2025. The company made the announcement via a news release dated November 5, 2025, which is included as Exhibit 99.1.
The information in the news release is furnished and not deemed filed under the Securities Exchange Act of 1934, and is incorporated by reference only if expressly stated in a future filing. Adient’s ordinary shares trade on the NYSE under the symbol ADNT.
Adient plc amended its Amended and Restated Revolving Credit Agreement. The change extends the maturity date to a date that is five years from October 17, 2025 and sets aggregate lender commitments at $1,000,000,000. The agreement continues to be guaranteed on a secured basis by the company and certain material wholly owned restricted subsidiaries.
The facility remains administered by JPMorgan Chase Bank, N.A. as administrative and collateral agent, with Adient US LLC as lead borrower. This amendment refreshes the tenor of the revolving credit line while aligning the committed size at $1.0 billion, preserving secured guarantees across key subsidiaries.
Dimensional Fund Advisors LP reported beneficial ownership of 4,215,764 shares of Adient PLC common stock, representing
Hotchkis and Wiley Capital Management, LLC filed an amendment to Schedule 13G reporting beneficial ownership of 3,251,560 ordinary shares of Adient plc, equal to 3.87% of the class. The filing states HWCM has sole dispositive power over 3,251,560 shares and sole voting power over 2,908,460 shares, with no shared voting or dispositive power reported. HWCM is identified as a Delaware investment adviser with a principal business address in Los Angeles. The filing includes a certification that the shares are held in the ordinary course of business and not for the purpose of changing control. The report is signed by Tina H. Kodama, Chief Compliance Officer, dated 08/13/2025.
Adient plc disclosed that representatives will hold meetings with certain investors in August 2025 and furnished the investor presentation used at those meetings as Exhibit 99.1 to this Form 8-K. The company states the presentation is furnished and therefore not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings except where expressly stated. The filing identifies Adient ordinary shares (par value $0.001) trading as ADNT on the New York Stock Exchange and lists the Inline XBRL cover page as Exhibit 104.
Jerome J. Dorlack, who is listed as President and CEO and a director of Adient plc (ADNT), reported a sale of ordinary shares on 08/07/2025. The filing discloses a disposition of 12,000 ordinary shares at a weighted average price of $22.77 per share, with sale prices ranging from $22.76 to $22.90. Following the reported transaction, the reporting person beneficially owned 441,025 shares on a direct basis. No derivative securities were reported on this form. The Form 4 was signed by an attorney-in-fact, Brett L. Eilander, on 08/08/2025.
Adient plc submitted a Form 144 disclosing a proposed sale of 12,000 common shares acquired as restricted stock units on 11/18/2022. The shares are to be sold through Oppenheimer & Co. Inc. on the NYSE with an approximate aggregate market value of $271,119.00 and total shares outstanding listed as 81,245,928. The filing shows no securities sold by the reporting person in the past three months. The notice includes the signer’s representation that they are not aware of any undisclosed material adverse information about the issuer.